BioStem Technologies Inc (OTCMKTS:BSEM) Stock In Focus After New Appointment
Leading regenerative medicine company focusing on developing, manufacturing, and commercialization of placental derived tissue allografts, BioStem Technologies Inc (OTCMKTS:BSEM), on September 8, 2022, announced the appointment of Brandon Poe as Independent Board Member as well as Chair of the Audit Committee. Trading Data On Thursday, BSEM stock decreased 0.66% to $2.2700 with more than 300 shares, compared to its average volume of 3.10K shares. The stock moved within a range…